Negative Pressure Wound Therapy for Post-Surgical Wounds in Soft Tissue Sarcoma
(VAC Trial)
Trial Summary
What is the purpose of this trial?
Project Summary - Aggressive soft tissue cancers are commonly treated with radiation followed by surgery. These wounds have a very high rate of wound complications and infection (30%), resulting in more surgeries, longer hospital stays and complex nursing care. Previous research shows that negative pressure (vacuum) dressings applied to the incision at the end of surgery can reduce these complications. The Investigator and his team across Canada will perform a clinical trial comparing standard dressings to these vacuum dressings. The results of this study have the potential to immediately improve the quality of life of soft tissue cancer patients. It can also decrease the amount of time required in hospital and reduce the cost to the Canadian healthcare system.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Incisional Negative Pressure Wound Therapy (INPWT) for post-surgical wounds in soft tissue sarcoma?
Research shows that Incisional Negative Pressure Wound Therapy (iNPWT) is beneficial in promoting wound healing and reducing complications like infections and dehiscence (wound reopening) in high-risk surgical wounds. It has been effectively used in various surgical fields, suggesting potential benefits for post-surgical wounds in soft tissue sarcoma as well.12345
Is negative pressure wound therapy safe for humans?
Negative pressure wound therapy (NPWT) is generally considered safe and is widely used in various surgical fields to help wounds heal and reduce complications like infections and wound reopening. However, some studies mention potential issues like skin blistering or seroma (fluid buildup) that may need attention.12345
How does the treatment Incisional Negative Pressure Wound Therapy (INPWT) differ from other treatments for post-surgical wounds in soft tissue sarcoma?
Incisional Negative Pressure Wound Therapy (INPWT) is unique because it uses a vacuum system to promote healing by reducing tension on the wound and removing excess fluid, which can help prevent complications like infections and wound reopening. This approach is different from traditional dressings that do not actively manage wound tension or fluid evacuation.12345
Research Team
Joel Werier
Principal Investigator
Surgeon
Eligibility Criteria
Adults with lower extremity soft tissue sarcoma confirmed by pathology, who will receive preop radiation followed by limb-saving surgery. They must be able to consent and attend follow-ups. Excluded are those under 18, with benign diseases, prior radiation in the area not linked to current treatment, amputations, non-primary closures like grafts or flaps, life expectancy under 120 days, or allergies to adhesive dressings.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Radiation
Participants receive preoperative radiation therapy
Surgery and Dressing Application
Limb salvage surgery is performed, followed by application of either vacuum dressing or standard dressing for 7 days
Follow-up
Participants are monitored for wound complications, length of hospital stay, patient quality of life, satisfaction, and function
Treatment Details
Interventions
- Incisional Negative Pressure Wound Therapy (INPWT)
- VAC Wound Dressing
- Wound Dressing
Incisional Negative Pressure Wound Therapy (INPWT) is already approved in United States, Canada, European Union for the following indications:
- Wound complications following surgery
- Chronic wounds
- Diabetic foot ulcers
- Venous leg ulcers
- Prevention of wound complications after lower extremity sarcoma surgery with preoperative radiation therapy
- Wound complications following surgery
- Chronic wounds
- Diabetic foot ulcers
- Venous leg ulcers
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ottawa Hospital Research Institute
Lead Sponsor
Dr. J. Werier
Lead Sponsor